Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3

Brain Research

Volumn 1361, Issue , 2010, Pages 140-145

  Yamamoto Watanabe, Yukiko ^a   Watanabe, Mitsunori ^a   Jackson, Mandy ^b   Akimoto, Hiroyuki ^a   Sugimoto, Kazuhiro ^a   Yasujima, Minoru ^a   Wakasaya, Yasuhito ^a   Matsubara, Etsuro ^a   Kawarabayashi, Takeshi ^a   Harigaya, Yasuo ^c   Lyndon, Alastair R ^d   Shoji, Mikio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MAEBASHI RED CROSS HOSPITAL   (Japan)

^d HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Cerebrospinal fluid; Cystatin C; Neurological disorder

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C;

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CST3 GENE; DEMYELINATING NEUROPATHY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SHY DRAGER SYNDROME; TAUOPATHY;

AGED; AGED, 80 AND OVER; ALANINE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYSTATIN C; FEMALE; GLYCINE; HUMANS; IMMUNOASSAY; LATEX; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEPHELOMETRY AND TURBIDIMETRY; NERVOUS SYSTEM DISEASES; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; TAUOPATHIES;

EID: 78049255819     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.09.033     Document Type: Article

References (34)

1. M. Balbin, A. Grubb, and M. Abrahamson An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a SstII polymorphism Hum. Genet. 92 1993 206 207
2. L. Benussi, R. Ghidoni, T. Steinhoff, A. Alberici, A. Villa, F. Mazzoli, F. Nicosia, L. Barbiero, L. Broglio, E. Feudatari, S. Signorini, U. Finckh, R.M. Nitsch, and G. Binetti Alzheimer's disease-associated cystatin C variant undergoes impaired secretion Neurobiol. Dis. 13 2003 15 21
3. L. Bertram, M.B. McQueen, K. Mullin, D. Blacker, and R.E. Tanzi Systematic meta-analyses of Alzheimer's disease genetic association studies: the AlzGene database Nat. Genet. 39 2007 17 23
4. K. Beyer, J.I. Lao, M. Gomez, N. Riutort, P. Latorre, J.L. Mate, and A. Ariza Alzheimer's disease and the cystatin C gene polymorphism: an association study Neurosci. Lett. 315 2001 17 20
5. H.M. Cathcart, R. Huang, I.S. Lanham, E.H. Corder, and S.E. Poduslo Cystatin C as a risk factor for Alzheimer's disease Neurology 64 2005 755 757
6. F.C. Crawford, M.J. Freeman, J.A. Schinka, L.I. Abdullah, M. Gold, R. Hartman, K. Krivian, M.D. Morris, D. Richards, R. Duara, R. Anand, and M.J. Mullan A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease Neurology 55 2000 763 768
7. U. Finckh, H. von der Kammer, J. Velden, T. Michel, B. Andresen, A. Deng, J. Zhang, T. Muller-Thomsen, K. Zuchowski, G. Menzer, U. Mann, A. Papassotiropoulos, R. Heun, J. Zurdel, F. Holst, L. Benussi, G. Stoppe, J. Reiss, A.R. Miserez, H.B. Staehelin, G.W. Rebeck, B.T. Hyman, G. Binetti, C. Hock, J.H. Growdon, and R.M. Nitsch Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer's disease Arch. Neurol. 57 2000 1579 1583
8. S. Gilman, G.K. Wenning, P.A. Low, D.J. Brooks, C.J. Mathias, J.Q. Trojanowski, N.W. Wood, C. Colosimo, A. Durr, C.J. Fowler, H. Kaufmann, T. Klockgether, A. Lees, W. Poewe, N. Quinn, T. Revesz, D. Robertson, P. Sandroni, K. Seppi, and M. Vidailhet Second consensus statement on the diagnosis of multiple system atrophy Neurology 71 2008 670 676
9. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society J. Peripher. Nerv. Syst. 10 2005 220 228
10. C. Lin, S.T. Wang, C.W. Wu, L.J. Chuo, and Y.M. Kuo The association of a cystatin C gene polymorphism with late-onset Alzheimer's disease and vascular dementia Chin. J. Physiol. 46 2003 111 115
11. I. Litvan, Y. Agid, D. Calne, G. Campbell, B. Dubois, R.C. Duvoisin, C.G. Goetz, L.I. Golbe, J. Grafman, J.H. Growdon, M. Hallett, J. Jankovic, N.P. Quinn, E. Tolosa, and D.S. Zee Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop Neurology 47 1996 1 9
12. I. Litvan, K.P. Bhatia, D.J. Burn, C.G. Goetz, A.E. Lang, I. McKeith, N. Quinn, K.D. Sethi, C. Shults, and G.K. Wenning Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders Mov. Disord. 18 2003 467 486
13. H. Maruyama, Y. Izumi, M. Oda, T. Torii, H. Morino, H. Toji, K. Sasaki, H. Terasawa, S. Nakamura, and H. Kawakami Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer's disease Neurology 57 2001 337 339
14. H. Maruyama, H. Morino, H. Ito, Y. Izumi, H. Kato, Y. Watanabe, Y. Kinoshita, M. Kamada, H. Nodera, H. Suzuki, O. Komure, S. Matsuura, K. Kobatake, N. Morimoto, K. Abe, N. Suzuki, M. Aoki, A. Kawata, T. Hirai, T. Kato, K. Ogasawara, A. Hirano, T. Takumi, H. Kusaka, K. Hagiwara, R. Kaji, and H. Kawakami Mutations of optineurin in amyotrophic lateral sclerosis Nature 465 2010 223 226
15. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
16. R.G. Miller, T.L. Munsat, M. Swash, and B.R. Brooks Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology Committee on Research J. Neurol. Sci. 169 1999 2 12
17. H. Mitsumoto, D.A. Chad, and E.P. Pioro Amyotrophic Lateral Sclerosis 1998 F.A. Davis Philadelphia
18. F. Mori, K. Tanji, Y. Miki, and K. Wakabayashi Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis J. Neuropathol. Exp. Neurol. 68 2009 1200 1206
19. F. Mori, K. Tanji, Y. Miki, A. Kakita, H. Takahashi, and K. Wakabayashi Relationship between Bunina bodies and TDP-43 inclusions in spinal anterior horn in amyotrophic lateral sclerosis Neuropathol. Appl. Neurobiol. 36 2010 345 352
20. A. Nagai, J.K. Ryu, M. Terashima, Y. Tanigawa, K. Wakabayashi, J.G. McLarnon, S. Kobayashi, J. Masuda, and S.U. Kim Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B Brain Res. 1066 2005 120 128
21. A. Nagai, M. Terashima, A.M. Sheikh, Y. Notsu, K. Shimode, S. Yamaguchi, S. Kobayashi, S.U. Kim, and J. Masuda Involvement of cystatin C in pathophysiology of CNS diseases Front. Biosci. 13 2008 3470 3479
22. M. Neumann, D.M. Sampathu, L.K. Kwong, A.C. Truax, M.C. Micsenyi, T.T. Chou, J. Bruce, T. Schuck, M. Grossman, C.M. Clark, L.F. McCluskey, B.L. Miller, E. Masliah, I.R. Mackenzie, H. Feldman, W. Feiden, H.A. Kretzschmar, J.Q. Trojanowski, and V.M. Lee Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 2006 130 133
23. Y. Nishimoto, D. Ito, T. Yagi, Y. Nihei, Y. Tsunoda, and N. Suzuki Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43 J. Biol. Chem. 285 2010 608 619
24. K. Okamoto, S. Hirai, M. Amari, M. Watanabe, and A. Sakurai Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum Neurosci. Lett. 162 1993 125 128
25. G. Okamoto, T. Sakamoto, M. Kimura, Y. Ukishima, A. Sonoda, N. Mori, Y. Kato, T. Maeda, and Y. Kagawa Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients Clin. Biochem. 40 2007 485 490
26. G.M. Pasinetti, L.H. Ungar, D.J. Lange, S. Yemul, H. Deng, X. Yuan, R.H. Brown, M.E. Cudkowicz, K. Newhall, E. Peskind, S. Marcus, and L. Ho Identification of potential CSF biomarkers in ALS Neurology 66 2006 1218 1222
27. S. Ranganathan, E. Williams, P. Ganchev, V. Gopalakrishnan, D. Lacomis, L. Urbinelli, K. Newhall, M.E. Cudkowicz, R.H. Brown Jr., and R. Bowser Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis J. Neurochem. 95 2005 1461 1471
28. H. Ryberg, J. An, S. Darko, J.L. Lustgarten, M. Jaffa, V. Gopalakrishnan, D. Lacomis, M. Cudkowicz, and R. Bowser Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics Muscle Nerve 42 2010 104 111
29. J. Sreedharan, I.P. Blair, V.B. Tripathi, X. Hu, C. Vance, B. Rogelj, S. Ackerley, J.C. Durnall, K.L. Williams, E. Buratti, F. Baralle, J. de Belleroche, J.D. Mitchell, P.N. Leigh, A. Al-Chalabi, C.C. Miller, G. Nicholson, and C.E. Shaw TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis Science 319 2008 1668 1672
30. B. Sun, Y. Zhou, B. Halabisky, I. Lo, S.H. Cho, S. Mueller-Steiner, N. Devidze, X. Wang, A. Grubb, and L. Gan Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease Neuron 60 2008 247 257
31. S. Tsuji-Akimoto, I. Yabe, M. Niino, S. Kikuchi, and H. Sasaki Cystatin C in cerebrospinal fluid as a biomarker of ALS Neurosci. Lett. 452 2009 52 55
32. P.N. Valdmanis, H. Daoud, P.A. Dion, and G.A. Rouleau Recent advances in the genetics of amyotrophic lateral sclerosis Curr. Neurol. Neurosci. Rep. 9 2009 198 205
33. M. Watanabe, M. Jackson, M. Ikeda, K. Mizushima, M. Amari, M. Takatama, S. Hirai, Y. Ikeda, M. Shizuka-Ikeda, and K. Okamoto Genetic analysis of the cystatin C gene in familial and sporadic ALS patients Brain Res. 1073-1074 2006 20 24
34. Y.J. Zhang, Y.F. Xu, C. Cook, T.F. Gendron, P. Roettges, C.D. Link, W.L. Lin, J. Tong, M. Castanedes-Casey, P. Ash, J. Gass, V. Rangachari, E. Buratti, F. Baralle, T.E. Golde, D.W. Dickson, and L. Petrucelli Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity Proc Natl Acad Sci U S A106 2009 7607 7612